Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes
US-12173314-B2 · Dec 24, 2024 · US
US2016263281A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016263281-A1 |
| Application number | US-201615040936-A |
| Country | US |
| Kind code | A1 |
| Filing date | Feb 10, 2016 |
| Priority date | Feb 11, 2015 |
| Publication date | Sep 15, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described herein are compositions of collagen and micronized placental tissue components, methods for producing the same and methods for using the same for wound healing, repairing damaged tendons, cosmetic applications and covering biocompatible materials and/or devices.
Opening claim text (preview).
What is claimed is: 1 . A composition comprising water, soluble collagen and micronized placental tissue components such that the composition is an integrated admixture having apparent homogeneity. 2 . The composition of claim 1 which is a coherent and flexible mass. 3 . The composition of claim 1 , wherein the micronized placental tissue components comprise micronized amnion, micronized chorion, micronized Wharton's jelly, or any combination thereof. 4 . The composition of claim 1 , wherein the micronized placental tissue components have a particle size less than 400 μm. 5 . The composition of claim 1 , wherein the micronized placental tissue components comprise a micronized tissue graft comprising an amnion layer and a chorion layer, wherein the chorion layer is layered directly over the amnion layer, and further wherein the amnion layer has an exposed basement membrane and an intact fibroblast component. 6 . The composition of claim 1 , wherein the micronized placental tissue components comprise a micronized tissue graft comprising an amnion layer and a chorion layer, wherein the chorion layer is layered directly over the amnion layer, and further wherein the amnion layer has an intact epithelial cell layer and an intact fibroblast component. 7 . The composition of claim 1 , wherein the collagen is human collagen. 8 . The method of claim 1 , wherein the collagen is an aqueous collagen material comprising from about 0.1% to about 2% collagen. 9 . The composition of claim 1 , wherein the weight ratio of the micronized placental tissue components to the collagen is from about 3:1 to about 100:1. 10 . The composition of claim 1 , wherein the weight ratio of micronized placental tissue components to collagen is about 100:1 to about 300:1. 11 . The composition of claim 10 , wherein the composition is coherent and flexible under physiological conditions. 12 . The composition of claim 1 , wherein the composition is obtained by ejecting a precursor composition comprising aqueous/gelatinous collagen and micronized placental tissue components. 13 . A method for transforming an aqueous/gelatinous collagen mass into a coherent and flexible composition said method comprising: a. incorporating sufficient micronized placental tissue components into an aqueous collagen material; and b. applying sufficient force and shear to the composition so as to transform the compositions into a coherent, flexible mass. 14 . The method of claim 13 , wherein the aqueous collagen material comprises from about 0.1% to about 2% collagen. 15 . The method of claim 13 , wherein the micronized placental tissue components comprise micronized amnion, micronized chorion, micronized Wharton's jelly, or any combination thereof. 16 . The method of claim 13 , wherein the placental tissue components have a particle size less than 400 μm. 17 . The method of claim 13 , wherein the collagen is human collagen. 18 . The method of claim 13 , wherein the weight ratio of the micronized placental tissue components to the collagen is from about 100:1 to about 300:1. 19 . A method for treating a wound in a subject in need thereof comprising administering to the wound an effective amount of the composition of claim 1 . 20 . A method for treating a cosmetic defect in a subject in need thereof comprising administering to the wound an effective amount of the composition of claim 1 .
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
for non-specific disorders of the connective tissue · CPC title
for treating wounds, ulcers, burns, scars, keloids, or the like · CPC title
Ingredients of undetermined constitution or reaction products thereof · CPC title
Collagen · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.